Primary congenital glaucoma usually requires timely surgery, while juvenile and secondary forms need their own approach. Corneal clouding or a normal diameter alone cannot separate glaucoma from a dystrophy. Follow both structural control and amblyopia/visual rehabilitation.
Terminology and draft status
Terminology review is not complete. Selected actual WHO UMD queries and their limits are recorded in terminology.md; they do not approve the whole translation.
01Recognise pressure-related growth without treating all children alike
In primary congenital glaucoma (PCG), developmental outflow abnormality can raise pressure and stretch the young eye, causing buphthalmos/hydrophthalmos, axial elongation, corneal changes and optic-nerve injury. The original corneal growth around 3–4 years and scleral distensibility up to 10 years have a traceable historical AAO textbook context; they are approximate developmental descriptions, not sharp universal diagnostic cutoffs. 1 2 3
PCG usually needs timely angle surgery; medicines may bridge to surgery or supplement it. This does not make every juvenile or secondary glaucoma solely surgical. The original “less than 10% effectiveness” and “less than 10% pressure reduction” are different claims with unresolved populations and endpoints, not a verified universal efficacy estimate. Prompt treatment also needs refraction and amblyopia care; pressure control alone is not the visual outcome. 1 2
02Classify onset and interpret genetic risk in context
The original PCG categories are neonatal 0–1 month, infantile 1–24 months and late onset after 24 months. Source boundary conventions overlap, so record the actual source rather than force a universal definition. The historical JOAG range 4–40 years is used in the identified AAO export; other classifications differ. High pressure and myopia can accompany JOAG without defining every case. Neonatal presentation may indicate more severe disease and worse prognosis, but onset age alone does not determine every outcome. 1 2 3
The original bilateral 70%, male predominance, 50% diagnosed at 1–12 months and up to 40% recessive inheritance are population-dependent historical descriptions. Most cases may be sporadic, while CYP1B1, LTBP2 and ANGPT1/TEK require gene- and phenotype-specific interpretation; LTBP2-associated megalocornea/lens disease is not automatically isolated PCG. Do not assign one recessive or dominant risk to every listed gene. 1 2 3
The original 2% sibling-recurrence claim is not what the identified AAO text describes: its historical 2% relates to an affected person’s offspring without known family history. These are different relationships, and the underlying primary evidence remains unread here. Use pedigree/genotype-specific counselling rather than quoting 2% as every sibling’s risk. 1 3
03Combine cornea, pressure, nerve and serial measurements
Epiphora, photophobia and blepharospasm with enlargement or clouding should trigger specialist assessment. Haab striae are breaks in Descemet’s membrane associated with stretching; note their pattern and alternative causes of corneal breaks. Increasing axial length, myopic shift, optic-disc change and corneal growth matter together rather than naming diameter the single most objective progression measure. 1 2 3
The original text gives >11 mm below 1 year and >12 mm at 1 year, while its table labels >11 mm neonatal and >12 mm at 1 year; it also flags >13 or 14 mm. These are not interchangeable age rules. The historical criteria reconciliation uses age-specific 11/12/13 mm examples; verify the precise source age band and serial growth rather than declaring every value diagnostic. Normal diameter with oedema does not exclude glaucoma. 1 2 3
Use an awake examination where reliable; EUA is needed when essential information cannot otherwise be obtained, not for every child. Record the tonometer, anaesthetic agent/depth/time and airway manipulation, plus gonioscopy, diameter, pachymetry, axial length, refraction and optic nerve. Tonopen, Perkins and pneumotonometry are methods, not interchangeable values; the original anaesthetic 10–20% decrease is not a fixed correction to awake IOP. 1 2 3
IOP >21 mmHg alone does not establish childhood glaucoma; require the relevant combination of signs and reproducible findings. C/D >0.3 is a historical newborn description rather than a universal cutoff; asymmetry >0.2 also needs disc size, rim and course. Corneal thickness and oedema affect tonometry in method-dependent ways; no fixed CCT correction reconstructs true pressure. The conflicting EGS suspect inequality remains documented rather than silently corrected. 1 2 3
04Work through CHED and secondary syndromic disease
Congenital hereditary endothelial dystrophy (CHED) can produce bilateral corneal clouding and marked thickening. The original 1100–1200 µm is a case-style range with unresolved source, not a diagnostic threshold. Normal diameter or a seemingly normal pressure does not exclude glaucoma, especially when oedema affects measurement; assess the complete phenotype before deciding against or for glaucoma surgery. 1 2 8
The historical dominant “CHED 1” has been reassigned within posterior polymorphous corneal dystrophy (PPCD) in modern terminology; recessive CHED, historically “CHED 2”, remains distinct. Retain the original labels with explanation rather than assume the exact genetic diagnosis from clouding. UBM and selected corneal tomography such as Pentacam can add information, but image quality and opacity limit what each can establish. 1 8
Axenfeld–Rieger can include glaucoma, dental and craniofacial abnormalities; the original 50% glaucoma risk is a population-level teaching estimate. Aniridia-associated glaucoma risk is not a universal 50% WAGR risk: Wilms tumour risk depends especially on a deletion involving WT1 as well as PAX6. Arrange genetic/systemic assessment and age/risk-appropriate renal surveillance rather than declaring all isolated or inherited aniridia identical. WAGR denotes Wilms tumour, aniridia, genitourinary anomalies and developmental impairment; the syndrome name is not proof that every feature or the same tumour risk is present in a given child. 1 2 3
Sturge–Weber can involve raised episcleral venous pressure and diffuse choroidal haemangioma, classically a “tomato-catsup” fundus. The sign is not present in every case and does not replace assessment of glaucoma mechanism. Consider choroidal effusion/haemorrhagic complications and plan surgery with an experienced service rather than apply a standard PCG pathway without modification. 1 2
05Choose surgery for anatomy and prior response
Goniotomy needs adequate angle visualisation; trabeculotomy can be useful when corneal clouding prevents a direct view. The choice also depends on angle anatomy, prior surgery and expertise, not transparency alone. Original success rates of 70–90% in Western settings versus <50% in the Middle East lack matched severity, outcome definitions and follow-up, so they cannot establish a geographic causal difference. The original operative terms goniotomy ab interno and trabeculotomy ab externo describe the approach, not a complete operative protocol. 1 2 3
The original trabeculotomy “enhanced by deep sclerectomy”, “Window-Defect” and 11–15% unidentifiable Schlemm canal/iris-prolapse scenario are retained as a named technical discussion. Their exact primary series, operative definition and risk denominator are unresolved; they are not a universal operative recipe or a validated indication in every difficult canal. 1
Drainage devices or cyclodestruction may be considered after inadequate control, with case-specific sequencing. Ahmed selection requires globe dimensions, quadrant and posterior clearance; AL <21 mm alone is not a verified universal FP8 rule. The March 2025 drawings show FP7 plate length 16.0 mm and area 184 mm2, FP8 11.0 mm and 102 mm2; the original FP8 10 mm remains a historical unresolved model value, not silently replaced as evidence of a design change. 1 3 4 5
Micropulse cyclophotocoagulation (CPC) is a cyclodestructive approach with its own energy/protocol and re-treatment risks. Its use in a complex Cornelia-de-Lange case does not prove that it is always the final option or superior to alternative surgery. Assess residual vision, anatomy, prior operations and family goals, with explicit discussion of repeat treatment and visual risk. 1 2
06Use medicines with product-specific child safety limits
Small body mass and systemic absorption increase adverse-effect concerns: carbonic-anhydrase inhibitors may cause metabolic acidosis, and beta-blockers bradycardia or bronchospasm. Medication choice, route and dose need paediatric specialist assessment and the actual product information; do not extrapolate an adult regimen. Medicines may assist preoperative corneal clearing or postoperative control without replacing indicated surgery. 1 2
German Alphagan 0.2% information of March 2026 contraindicates use below 2 years and does not recommend use below 12; safety/efficacy at 2–12 are unestablished. Ages 2–7 and/or weight ≤20 kg require particular caution and close monitoring for somnolence. Thus 20 kg is a risk marker, not the same absolute contraindication as age <2, and passing that age does not establish paediatric approval or safety. 1 6
07Plan long-term visual rehabilitation and honest guideline use
Monitor pressure, corneal diameter, axial growth, optic nerve and usable OCT/fields over time, with cycloplegic refraction, anisometropia management and amblyopia treatment. Specialist follow-up and family support remain necessary lifelong; a successful pressure operation does not complete visual rehabilitation or remove recurrence risk. 1 2
The original invokes an unspecified German S2k childhood-glaucoma standard. The current BVA/DOG catalogue instead identifies historical childhood-glaucoma guidance 15b dated 12/1998; WGA consensus and EGS/AAO material are different sources and methods. Do not call them one current legally binding surgical algorithm. Preserve the unresolved guideline identity and verify concrete recommendations before publication. 1 2 3 7
08Use the summary as a decision aid with limits
The table retains all 8 original topics and separates historical lecture values from current selected product drawings or safety text. It does not supply an individual diagnosis, operative sizing calculator or prescription. Continue unresolved source and translation work alongside specialist clinical review of all 3 language versions. 1 2 3 4 5 6 7 8
| Topic | Original concept retained | Source-qualified next step | Exception or warning |
|---|---|---|---|
| Corneal diameter | Original neonatal >11 mm, 1 year >12 mm, >13 mm warning | Check exact age band and serial growth with full examination | Normal diameter with oedema does not exclude PCG |
| IOP | Original >21 mmHg and anaesthesia 10–20% reduction | Combine reproducible pressure and morphology; record anaesthesia | No fixed oedema/CCT correction or stand-alone pressure diagnosis |
| Brimonidine | Contraindicated <2 years; original <20 kg rule | German product: not recommended <12, caution 2–7 and/or ≤20 kg | Systemic/CNS depression; weight marker is not identical absolute contraindication |
| Surgery | Goniotomy with view, trabeculotomy when cloudy | PCG angle approach by anatomy and expertise | Enhanced technique/absent canal 11–15% remains unverified technical claim |
| Ahmed valve | Original FP7 16 mm/FP8 10 mm and AL <21 mm rule | 2025 drawings: FP7 16.0 mm/184 mm2, FP8 11.0 mm/102 mm2 | Assess globe/quadrant/optic-nerve clearance, not AL-only selection or inferred design change |
| CHED | Original 1100–1200 µm example and historical CHED 1/2 | Phenotype/genetics; clarify PPCD reassignment | Thickness or normal diameter alone does not settle glaucoma differential |
| Aniridia | Original table 50% glaucoma risk, not 50% WAGR | Genetic assessment for WT1/PAX6 deletion and renal-risk pathway | Do not apply identical Wilms screening to every isolated/inherited case |
| Sturge–Weber | Tomato-catsup fundus/diffuse choroidal haemangioma | Assess episcleral pressure and choroidal involvement | Plan for choroidal effusion/bleeding risks in intraocular surgery |
What are the main learning points?
Primary congenital glaucoma usually requires timely surgery, while juvenile and secondary forms need their own approach. Corneal clouding or a normal diameter alone cannot separate glaucoma from a dystrophy. Follow both structural control and amblyopia/visual rehabilitation.
When is assessment urgent?
Tearing, photophobia and blepharospasm with corneal clouding or enlargement need prompt specialist assessment. Acute pain, rapid visual loss, marked inflammation or infection, pressure rise, leukocoria or neurological warning signs requires urgent assessment.
References and access status
- 1Immutable original export; paediatric glaucoma synthesis attributed to Dr Al-Sheikha; attribution not authenticated
Complete export read; original attribution and any recording/transcript or appointment not independently verified.
- 2WGA Consensus 9: childhood glaucoma, 2013
Selected official online sections 1–8 read 15 November 2026, not complete book or original criteria chapter pp3–10. Expert consensus is not a comparative treatment trial.
- 3Review 007: source reconciliation for CGRN, EGS and AAO
Complete repository reconciliation read 15 November 2026; reuses actual 3 November selected source access, not independent new reading of AAO full chapter or EGS PDF. Original AAO p188 image, WGA pp3–10, EGS inequality discrepancy and primary epidemiological/surgical studies remain unresolved.
- 4New World Medical Ahmed FP7, IFU 50-0180 Rev B 2025-03
Stored official German drawing printed p17/PDF p18 independently visually read 15 November 2026; prior 3 November selected indication scope reused. Not entire multilingual IFU, historical revision or comparative paediatric study.
- 5New World Medical Ahmed FP8, IFU 50-0189 Rev B 2025-03
Stored official German drawing printed p17/PDF p18 independently visually read 15 November 2026: plate length 11.0 mm, area 102 mm2. Prior selected indication scope reused. No inferred device-design change or universal AL calculator rule.
- 6German Alphagan 0.2% m/V product information, March 2026
Stored official German text sections 4.2–4.4 independently reread 15 November 2026; prior 3 November paediatric 4.8 access reused, not entire current label or original clinical trial. Product-specific German restrictions, not universal class-wide thresholds.
- 7BVA/DOG current catalogue: childhood glaucoma 15b
Official catalogue read 15 November 2026: 15b childhood glaucoma dated 12/1998. Does not verify the original unspecified current S2k paediatric-glaucoma guideline.
- 8Review 007: terminology and CHED source record
Historical review 007 source record reused; current primary IC3D full text and individual CHED case source not newly appraised for 141. Source and terminology questions remain explicit.
Original lecture link
For patients
Early examination can distinguish raised pressure from other causes of cloudy or enlarged eyes. Treatment protects the optic nerve, while glasses and amblyopia care remain important for the child’s developing vision.
Examination and selected tests guide individual treatment and follow-up; this educational text cannot replace your own assessment.
Tearing, photophobia and blepharospasm with corneal clouding or enlargement need prompt specialist assessment. Acute pain, rapid visual loss, marked inflammation or infection, pressure rise, leukocoria or neurological warning signs requires urgent assessment.
Tearing, photophobia and blepharospasm with corneal clouding or enlargement need prompt specialist assessment. Acute pain, rapid visual loss, marked inflammation or infection, pressure rise, leukocoria or neurological warning signs requires urgent assessment.